Jubilant Pharmova is currently trading at Rs. 435.20, up by 25.50 points or 6.22% from its previous closing of Rs. 409.70 on the BSE.
The scrip opened at Rs. 417.60 and has touched a high and low of Rs. 437.15 and Rs. 413.45 respectively. So far 23034 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 925.00 on 27-May-2021 and a 52 week low of Rs. 384.85 on 31-Mar-2022.
Last one week high and low of the scrip stood at Rs. 437.15 and Rs. 384.85 respectively. The current market cap of the company is Rs. 6865.02 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 24.24% and 25.08% respectively.
Jubilant Pharmova has entered into Share Purchase agreement, and Share Subscription and Shareholders agreement on April 1, 2022 for acquiring equity and preference shares of SPV Laboratories (Greencure). Greencure products have differentiated positioning, combining the best of Ayurveda and German herbal science.
The company has obtained multiple international certifications to strengthen their credibility. The market is being driven by a growing shift towards natural products, as well as rise in chronic diseases and growing health awareness. There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution. Aggregate cost of acquisition is Rs 8.75 crore for acquiring 25.21% stake.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |